TrialPloS one2025

Melatonin agonist tasimelteon (HETLIOZ®) improves sleep in patients with primary insomnia: A multicenter, randomized, double-blind, placebo-controlled trial.

Naoise C Synnott et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.